Mark R. Ziebell - Apr 30, 2024 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Role: V. P., General Counsel
Signature: /s/ Mark R. Ziebell
Stock symbol: CDMO
Transactions as of: Apr 30, 2024
Transactions value $: -$12,157
Form type: 4
Date filed: 5/2/2024, 08:21 PM
Previous filing: Apr 11, 2024
Next filing: Jul 2, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDMO	Common Stock, $0.001 par value	Sale	-$12.2K	-1.64K	-2.47%	$7.40	64.8K	Apr 30, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSUs") which vested on April 9, 2024. This sale does not represent a discretionary trade by the reporting person. For further information regarding the RSUs vested on April 9, 2024, refer to footnotes 2, 3 and 4 of the reporting person's Form 4 filed with the SEC on April 11, 2024.
F2	Represents a weighted average sales price per share. These shares were sold at prices ranging from $7.33 to $7.40. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Content

Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSUs") which vested on April 9, 2024. This sale does not represent a discretionary trade by the reporting person. For further information regarding the RSUs vested on April 9, 2024, refer to footnotes 2, 3 and 4 of the reporting person's Form 4 filed with the SEC on April 11, 2024.

Represents a weighted average sales price per share. These shares were sold at prices ranging from $7.33 to $7.40. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.